A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 39/44 (2006.01) C07K 16/22 (2006.01) G01N 33/533 (2006.01) G01N 33/534 (2006.01) G01N 33/535 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2499207
Embodiments of the invention described herein relate to antibodies directed to platelet derived growth factor-DD (PDGF-DD) and uses of such antibodies. The antibodies of the invention find use as diagnostics and as treatments for diseases associated with the overproduction of PDGF-DD. In particular, in accordance with embodiments of the invention, the use of anti-PDGF-DD antibodies for the treatment of nephritis and related disorders, including diseases caused by mesangial proliferation is provided.
Des modes de réalisation de l'invention concernent des anticorps dirigés contre le facteur de croissance DD dérivé des plaquettes (PDGF-DD) et des applications de ces anticorps. Ces anticorps sont utilisés pour le diagnostic et le traitement de maladies liées à la surproduction de PDGF-DD. Certains modes de réalisation de l'invention concernent plus particulièrement l'utilisation d'anticorps anti-PDGF-DD pour le traitement de la néphrite et de troubles associés, y compris de maladies induites par la prolifération mésangiale.
Floege Juergen
Gazit-Bornstein Gadi
Keyt Bruce
Larochelle William J.
Lichenstein Henri
Abgenix Inc.
Amgen Fremont Inc.
Curagen Corporation
Ridout & Maybee Llp
LandOfFree
Method for the treatment of nephritis using anti-pdgf-dd... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of nephritis using anti-pdgf-dd..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of nephritis using anti-pdgf-dd... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1973051